Oral L-NAME supplementation accelerates the progression of kidney disease in diabetic mice. Nicese MN, Koudijs A, Lalai R, Avramut C, et al. Biochem Biophys Res Commun 2025;790:152859.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nicese MN, Koudijs A, Lalai R, Avramut C, et al. Oral L-NAME supplementation accelerates the progression of kidney disease in diabetic mice. Biochem Biophys Res Commun 2025;790:152859.
PMID: 41172805